BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23001041)

  • 1. NEDDylation controls the target specificity of E2F1 and apoptosis induction.
    Aoki I; Higuchi M; Gotoh Y
    Oncogene; 2013 Aug; 32(34):3954-64. PubMed ID: 23001041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.
    Yang SZ; Lin FT; Lin WC
    EMBO Rep; 2008 Sep; 9(9):907-15. PubMed ID: 18660752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
    Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
    Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
    Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
    J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
    Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
    Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated expression of E2F1 promotes proteolytic degradation of tumor suppressor p73 and inhibits its transcriptional activity.
    Ozaki T; Okoshi R; Ono S; Kubo N; Nakagawara A
    Biochem Biophys Res Commun; 2009 Sep; 387(1):143-8. PubMed ID: 19576172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1.
    Wu S; Murai S; Kataoka K; Miyagishi M
    Biochem Biophys Res Commun; 2008 Jan; 365(1):75-81. PubMed ID: 17980704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEDDylation regulates E2F-1-dependent transcription.
    Loftus SJ; Liu G; Carr SM; Munro S; La Thangue NB
    EMBO Rep; 2012 Sep; 13(9):811-8. PubMed ID: 22836579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.
    Cassimere EK; Pyndiah S; Sakamuro D
    Cell Death Differ; 2009 Dec; 16(12):1641-53. PubMed ID: 19629135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of E2F1 apoptotic target genes in response to DNA damage.
    Pediconi N; Ianari A; Costanzo A; Belloni L; Gallo R; Cimino L; Porcellini A; Screpanti I; Balsano C; Alesse E; Gulino A; Levrero M
    Nat Cell Biol; 2003 Jun; 5(6):552-8. PubMed ID: 12766778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of telomerase activity by the p53 family member p73.
    Beitzinger M; Oswald C; Beinoraviciute-Kellner R; Stiewe T
    Oncogene; 2006 Feb; 25(6):813-26. PubMed ID: 16205639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation status of E2F-1 has an important role in the regulation of E2F-1-mediated transactivation of tumor suppressor p73.
    Ozaki T; Okoshi R; Sang M; Kubo N; Nakagawara A
    Biochem Biophys Res Commun; 2009 Aug; 386(1):207-11. PubMed ID: 19523927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.
    Urist M; Tanaka T; Poyurovsky MV; Prives C
    Genes Dev; 2004 Dec; 18(24):3041-54. PubMed ID: 15601819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
    Marabese M; Vikhanskaya F; Rainelli C; Sakai T; Broggini M
    Nucleic Acids Res; 2003 Nov; 31(22):6624-32. PubMed ID: 14602923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.
    Ozono E; Komori H; Iwanaga R; Tanaka T; Sakae T; Kitamura H; Yamaoka S; Ohtani K
    Genes Cells; 2012 Aug; 17(8):660-72. PubMed ID: 22702391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
    Ray RM; Bhattacharya S; Johnson LR
    Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative regulation of p73 promoter by Yin Yang 1 and E2F1.
    Wu S; Murai S; Kataoka K; Miyagishi M
    Nucleic Acids Symp Ser (Oxf); 2007; (51):347-8. PubMed ID: 18029729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3.
    Chen D; Chen Y; Forrest D; Bremner R
    Cell Death Differ; 2013 Jul; 20(7):931-40. PubMed ID: 23558950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas.
    Liontos M; Niforou K; Velimezi G; Vougas K; Evangelou K; Apostolopoulou K; Vrtel R; Damalas A; Kontovazenitis P; Kotsinas A; Zoumpourlis V; Tsangaris GT; Kittas C; Ginsberg D; Halazonetis TD; Bartek J; Gorgoulis VG
    Am J Pathol; 2009 Jul; 175(1):376-91. PubMed ID: 19541929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.